The cost-effectiveness of guideline-driven use of drug-eluting stents: propensity-score matched analysis of a seven-year multicentre experience.

Thathya Venu Ariyaratne,Zanfina Ademi,Richard Ofori-Asenso,Molla Huq,Stephen J. Duffy,Bryan P. Yan,Andrew E. Ajani,David J. Clark,Baki Billah,Angela Brennan,Gishel New,Nick Andrianopoulos,Christopher M. Reid

The cost-effectiveness of guideline-driven use of drug-eluting stents: propensity-score matched analysis of a seven-year multicentre experience.

2020

Thathya Venu Ariyaratne
Zanfina Ademi
Richard Ofori-Asenso
Molla Huq
Stephen J. Duffy
Bryan P. Yan
Andrew E. Ajani
David J. Clark
Baki Billah
Angela Brennan
Gishel New
Nick Andrianopoulos
Christopher M. Reid

AbstractBackground: In routine clinical practice, the implantation of a drug-eluting stent (DES) versus a bare metal stent (BMS) for percutaneous coronary intervention (PCI) has been guided by crit...

Keywords:

Medicine
Stent
Guideline
Drug
Surgery
Percutaneous coronary intervention
Conventional PCI
Bare-metal stent
Diabetes mellitus
Propensity score matching
Anesthesia
Population
Internal medicine
cost effectiveness

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations